Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Update

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the target of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 300 shares, a decline of 25.0% from the February 13th total of 400 shares. Based on an average trading volume of 32,600 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Integrated BioPharma Stock Performance

Shares of INBP stock opened at $0.32 on Tuesday. The firm has a market cap of $9.60 million, a price-to-earnings ratio of 10.57 and a beta of 0.89. Integrated BioPharma has a 52 week low of $0.16 and a 52 week high of $0.42. The firm’s 50-day simple moving average is $0.34 and its two-hundred day simple moving average is $0.30.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.